Clinical Study of Recombinant Human Granulocyte Colony-Stimulating Factor in Patients Undergoing Intensive Chemotherapy for Malignant Bone and Soft Tissue Tumors
In intensive chemotherapy for patients with malignant bone and soft tissue tumors, bone marrow toxicity is one of the most hazardous side effects. Recently recombinant forms of four human hematopoietic colony-stimulating factors have been purified [1–3], and their potential clinical application seem to be very promising for prevention of bone marrow suppression by chemotherapy. Reports on the effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on granulocytopenia induced by chemotherapy in patients with solid tumor have been published [4–9], but these studies are still in the experimental stage. In this paper, we evaluated the efficacy and feasibility of the use of rhG-CSF for rescue of chemotherapy in malignant bone and soft tissue tumors.
KeywordsSynovial Sarcoma Soft Tissue Tumor Intensive Chemotherapy Fibrous Histiocytoma Bone Marrow Toxicity
Unable to display preview. Download preview PDF.
- 1.Souza LM, Boone TC, Gabrilove J, Lai PH, Zsebo KM, Murdock DC, Chazin VR, Bruszewski J, Lu H, Chen K, Barendt J, Platzer E, Moore MAS, Mertelsmann R, Welte K (1986) Recombinant human granulocyte colony-stimulating factor: Effects on normal and leukemic myeloid cells. Science 232: 61–65PubMedCrossRefGoogle Scholar
- 2.Kawasaki ES, Ladner MB, Wang AM, Arsdell JV, Warren MK, Coyne MY, Schweickart VL, Lee MT, Wilson KJ, Boosman A, Stanley ER, Ralph P, Mark DF (1985) Molecular cloning of the complementary DNA encoding human macrophage colony-stimulating factor (CSF-1). Science 230: 291–296PubMedCrossRefGoogle Scholar
- 6.Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagota A, Fain K, Moore MAS, Clarkson B, Oettgen H, Alton K, Weite K, Souza LM (1988) Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 318: 1414–1422PubMedCrossRefGoogle Scholar
- 7.Brandt SJ, Peters WP, Atwater SK, Kurtberg J, Borowitz MJ, Jones RB, Shapall EJ, Bast RG, Gilbert CJ, Oette DH (1988) Effect of recombinant human granulocyte-macrophage colony-stimulating factors on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 318: 869–876PubMedCrossRefGoogle Scholar
- 8.Vadhan-Raj S, Buescher S, LeMaistre A, Keating M, Walters R, Ventura C, Hittelman W, Broxmeyer HE, Gutterman JU (1988) Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factors. Blood 72: 134–141PubMedGoogle Scholar
- 10.Ohsaki Y, Bungo M, Horichi N, Fujiwara Y, Minato K, Niimi S, Nakagawa K, Ohe Y, Sasaki S, Eguchi K, Sasaki Y, Saijo N (1989) Effects of recombinant human colony-stimulating factors on colony formation of lung cancer cell lines. Jpn J Cancer Chemother 16: 431–433Google Scholar
- 11.Shinto Y, Uchida A, Araki N, Ono K (1991) Enhancement of cell activity in malignant bone and soft tissue tumors by granulocyte colony stimulating factor. J Jpn Orthop Assoc 65: 12–59Google Scholar